Document is current

Article History

Received: 24 October 2025

Accepted: 1 February 2026

First Online: 28 March 2026

Declarations

:

: This letter was funded by Takeda Development Center Americas, Inc.

: Irmgard Andresen is an employee of Takeda Pharmaceuticals International AG, and holds stock/options in Takeda Pharmaceutical Company Limited. Natalie Khutoryansky is an employee of Cytel, contracted by Takeda Development Center Americas, Inc. Sarah Feeny is an employee of Ampersand Medical, contracted by Takeda Development Center Americas, Inc. Alissa Dangel is an employee of Takeda Pharmaceuticals USA, Inc., and holds stock/options in Takeda Pharmaceutical Company Limited.

: Ethical approval was not required for this letter as no study data were collected or analysed.

: Not applicable.

: Not applicable.

: Data sharing is not applicable to this article as no datasets were generated or analysed during the current study.

: Not applicable.

: I.A., N.K., S.L.F., and A.D. contributed to the conceptualisation, drafting and review of this letter. All authors read and approved the final version of the letter for submission.